글로벌 동물공통감염병 치료 시장 – 2029년까지의 산업 동향 및 예측

시장 분석 및 규모

최근 몇 년 동안, 인수공통감염증 치료 시장은 예측 기간 동안 빠르게 성장할 것으로 예상됩니다. 감염 , 병인 및 치료에 따라, 인수공통감염증은 경미한 것에서 치명적인 것까지 다양하며 심지어 사망에 이를 수도 있습니다. 세계보건기구(WHO)에 따르면, 인수공통감염증은 매년 10억 건 이상의 감염과 수백만 건의 사망을 초래하며, 전 세계적으로 새로운 전염병의 60%를 차지합니다. 인수공통감염증의 증가는 또한 혼잡한 환경, 열악한 위생, 기후 및 서식지 변화, 동물 사육 및 이해 부족에 기인합니다. 진단, 치료 및 백신 개발이 빠르게 진행되어 시장에서 인수공통감염증 치료에 대한 수요가 더욱 증가하고 있습니다.

Data Bridge Market Research는 인수공통감염병 치료 시장이 2021년에 368억 5천만 달러 규모였으며, 2029년까지 576억 8천만 달러에 도달할 것으로 예상하고, 2022년부터 2029년까지의 예측 기간 동안 5.76%의 CAGR을 기록할 것으로 분석했습니다. Data Bridge Market Research 팀이 큐레이팅한 시장 보고서에는 심층적인 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크가 포함되어 있습니다.

시장 정의

인수공통감염병은 동물에서 사람으로, 사람에서 동물로 전염되는 예측할 수 없는 질병 의 일종입니다 . 질병이 전파되는 방법에는 공기 중 전파, 직접적 상호작용, 질병을 유발하는 비활성적인 것과의 연결, 경구 흡수, 해충 등 다양한 방법이 있습니다. 개인은 도청기나 다른 야생 동물에 의해 퍼진 질병으로 인해 병에 걸리거나 죽을 수 있습니다. 동물이 인수공통감염병을 가지고 있을 때 항상 병들거나 아픈 것은 아니라는 점을 기억하는 것이 중요합니다. 몇몇 유기체는 건강해 보이지만, 사람을 아프게 할 수 있는 감염성 박테리아를 퍼뜨립니다. 항진균제, 항균제, 항생제는 이 질병에 대한 다양한 치료 옵션입니다.

보고 범위 및 시장 세분화

인수공통감염병 치료 시장 동향

운전자

• 인수공통감염병 의 유병률 증가

동물성 질병의 유병률이 증가함에 따라 치료 수요가 증가하고 시장 성장률이 더욱 높아질 것으로 예상됩니다. 인구 증가, 위생 악화, 기후 및 서식지 변화는 예측 기간 동안 시장 역학에 영향을 미치는 주요 요인입니다.   

• 의료 인프라에 대한 투자 증가

인수공통감염병 치료 시장의 성장률에 영향을 미치는 또 다른 중요한 요인은 의료 서비스 지출이 증가하고 있다는 점인데, 이는 인프라 개선에 도움이 됩니다.

게다가, 성형 수술에 대한 관심이 높아지면서 인수공통감염증 치료 시장이 확대될 것입니다. 또한, 가처분 소득이 높아지고 도시화가 증가하면서 인수공통감염증 치료 시장이 확대될 것입니다. 이와 함께, 질병에 특화된 새로운 치료법에 대한 수요가 증가하고 항생제 사용이 증가하면서 시장 성장률이 높아질 것입니다.

기회

• 연구개발 활동의 증가       

Moreover, the market's growth is fueled by an increase in the number of research and development activities. This will provide beneficial opportunities for the zoonotic disease treatment market growth. Along with this, rising approvals and launches of new zoonotic disease treatment drugs will further propel the market’s growth rate.

Moreover, rising investment for the development of advanced technologies and an increase in the number of emerging markets will provide beneficial opportunities for the zoonotic disease treatment market growth during the forecast period.

Restraints/Challenges

On the other hand, patent expiration of branded drugs and introduction of generics will obstruct the growth rate of market. The dearth of skilled professionals and lack of healthcare infrastructure in developing economies will challenge the zoonotic disease treatment market. Additionally, high capital investment required for research and development and the lack of awareness will restrain and further impede the growth rate of the market during the forecast period of 2022-2029.

This zoonotic disease treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the zoonotic disease treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Patient Epidemiology Analysis

Zoonotic disease treatment market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analyses of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

COVID-19 Impact on Zoonotic Disease Treatment Market

Since its emergence in December 2019, the COVID-19 virus has spread to nearly every country on the planet, prompting the World Health Organization (WHO) to declare it a public health emergency. This can be ascribed to severe disruptions in their respective manufacturing and supply-chain operations, resulting from multiple precautionary lockdowns and other limitations imposed by governments all over the world. The zoonotic disease treatment market is no exception. Furthermore, consumer preferences has decreased as people are now much more concentrated on removing non-essential expenses from their budgets as the wider economic situation of most people has been adversely impacted by this outbreak. Over the forecast period, the aforementioned factors are likely to have a negative impact on the zoonotic disease treatment market's revenue trajectory.

Global Zoonotic Disease Treatment Market Scope

The zoonotic disease treatment market is segmented on the basis of types, causative agent, drug class, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Types

• Rabies
• Tuberculosis
• Malaria
• Leishmaniasis
• Ebola Virus Disease
• Others

Based on types, the zoonotic disease treatment market is segmented into rabies, tuberculosis, malaria, leishmaniasis, Ebola virus disease, and others.

Causative Agent

• Bacteria
• Virus
• Nematode
• Rodents
• Ticks
• Others

Based on causative agent, the zoonotic disease treatment market is segmented into bacteria, virus, nematode, rodents, ticks, and others.

Drug Class

• Anti-fungal
• Anti-bacterial
• Antibiotics
• Others

Based on drug class, the zoonotic disease treatment market is segmented into anti-fungal, anti-bacterial, antibiotics, and others.

Route of Administration

• Oral
• Topical
• Others

The route of administration segment for global zoonotic disease treatment market is segmented into oral, topical and others.

 End-Users

• Hospitals
• Specialty Clinics
• Homecare
• Others

On the basis of end-users, the zoonotic disease treatment market is segmented into hospitals, specialty clinics, homecare and others.

Distribution Channel

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
• Others

On the basis of distribution channel, the zoonotic disease treatment market has also been segmented into hospital pharmacy, retail pharmacy, online pharmacy and others.

Zoonotic Disease Treatment Market Regional Analysis/Insights

The Zoonotic disease treatment market is analysed and market size insights and trends are provided by country, types, causative agent, drug class, route of administration, end-users and distribution channel as referenced above.

The countries covered in the Zoonotic disease treatment market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

North America dominates the zoonotic disease treatment market due to rapid urbanization and the rising prevalence of zoonotic disease. Additionally, growing focus of major key players on novel technology will further propel the market’s growth rate in this region.

Asia-Pacific are expected to grow during the forecast period of 2022 to 2029 due to rising number of population and rising healthcare expenditure in this region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Zoonotic Disease Treatment Market Share Analysis

The Zoonotic disease treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to zoonotic disease treatment market.

Some of the major players operating in the zoonotic disease treatment market are:

• F. Hoffmann-La Roche Ltd. (Switzerland)
• Mylan N.V. (US)
• Teva Pharmaceutical Industries Ltd.(Israel)
• Sanofi (France), Pfizer Inc. (US)
• GlaxoSmithKline plc (UK)
• Novartis AG (Switzerland)
• Sun Pharmaceutical Industries Ltd. (India)
• Gilead Sciences, Inc. (US)
• Apotex Inc. (Canada)
• Amneal Pharmaceuticals LLC. (US)
• Zydus Cadila (India)
• Aurobindo Pharma (India)
• Cipla Inc. (US)
• Hikma Pharmaceuticals PLC (UK)
• Dr. Reddy’s Laboratories Ltd. (India)
• WOCKHARDT (India)
• Bausch Health Companies Inc. (Canada)
• Lannett (US)
• Torrent Pharmaceuticals Ltd. (India) 

SKU-50355